Skip to main content

Professional Diploma in Clinical Research (PDCR) and Professional Certificate in Pharmacovigilance (PCPV) programs.

Dear Colleague,
Catalyst announces the admission for the Apr’16 batch of Professional Diploma in Clinical Research (PDCR) and Professional Certificate in Pharmacovigilance (PCPV) programs.

Now, you can recommend these programs to your friends/colleagues along with a fee waiver of Rs. 1000 and in turn can avail a free course for yourself. You have to simply e-mail us the name and contact number of the person whom you have authorized to avail the fee waiver and upon confirmation we would contact you for availing the desired offer

To receive the fee waiver coupon you can write to us at this id. Also, you can get a complimentary copy of ā€œThe Big Book of Clinical Researchā€ worth Rs. 4800 if your friends/colleagues join before 31st March 2016.

I look forward to your recommendation for the PCPV/PDCR programs.

Thanks and best regards,
Aditya G
Course Co ordinator
Catalyst Clinical Services Pvt. Ltd.
Unit No. 16, CSC-12, Block D1, Sector-16, Rohini, Delhi – 110089
M: +91 9818356273

Comments

Post a Comment

Popular posts from this blog

Intellectual Property Rights and Portfolio Management in Pharmaceuticals

  Introduction The pharmaceutical industry depends heavily on intellectual property (IP) rights to stay innovative and competitive. Without these protections, companies risk losing the chance to profit from their discoveries. Managing a strong IP portfolio helps maximize research and development (R&D) investments, open doors to licensing deals, and keep drugs on the market longer. Still, this field faces many hurdles, including tough patent laws worldwide and changing regulations. At the same time, emerging opportunities can give companies a competitive edge if they master IP management. Understanding Intellectual Property Rights in Pharmaceuticals What Are Intellectual Property Rights? IP rights are legal tools that protect creations and ideas. In pharma, they help companies control and profit from their inventions for a certain time. Types of IP relevant to drugs include patents, trademarks, trade secrets, and data exclusivity. Each has a role in defending the company’s i...

Pharma Companies HR contact information

Dear viewers of my blog, I am happy to share the HR contact details of Pharmaceutical companies. Contact Details Of Pharma HRs : Zaydus cadila-Goa gajendravernekar@zayduscadila.com 09623458512/08326615143 Teva-Goa Maryann.Braganza@teva.co.in sanjay.pandit@teva.co.in 0832 6685538 Glenmark-Goa Vittal hebbalkar hr executivr - 9923476869 anupbannatti@glenmark-generics.com 09604151586 Watson-Goa Jyosna.bagule@watsonpharm.co.in runa.divkar@watsonpharm.co.in goa@watsonpharm.co.in 0832 6690666/777 Unichem Labs-Goa abhiram.panshikar@unichemlabs.com R&D  suraj.jadhav@unichemlabs.com vikas.parkar@unichemlabs.com Indico-Goa goahplc@Indoco.com varun.keny@indoco.com anand.ingole@Indoco.com 0832 6624109 Encube-Goa hr@encubeethicals.com nidhi.b@encubeethicals.com 8322392223 Torrent pharma-Ahmdabad mayurdesai@torrentpharma.com 9879603921/22/23/24 Emcure-pune RPKulkarni@emcure.co.in           Kishor.Mule@emcur...

An Overview of Brazil Patent litigation

  An Overview of Brazil Patent litigation Brazil plays a crucial role in Latin America's intellectual property landscape, particularly when it comes to patent litigation. The country's strong legal framework, governed by the Industrial Property Act, creates an environment where patents can be protected and enforced effectively. The Brazilian patent system serves as a vital mechanism for: Protecting innovative technologies Securing market advantages Fostering economic development Promoting technological advancement For businesses and inventors, understanding Brazil's patent litigation system is essential for success in this emerging market. The system's unique characteristics, including its bifurcated approach to handling infringement and invalidity cases, create distinct challenges and opportunities. Recent years have witnessed a surge in patent litigation cases, particularly in: Pharmaceutical sectors Technology industries Telecommunications Manufacturing This increa...